Difference between revisions of "Eluvixtamab (AMG-330)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "Category:Chemotherapeutic" to "") Tags: mobile edit mobile web edit |
Warner-admin (talk | contribs) m (Text replacement - "Category:Antibody medications" to "") Tags: mobile edit mobile web edit |
||
| Line 6: | Line 6: | ||
[[Category:Immunotherapeutic]] | [[Category:Immunotherapeutic]] | ||
| − | + | ||
[[Category:T-cell activators]] | [[Category:T-cell activators]] | ||
[[Category:BiTE antibodies]] | [[Category:BiTE antibodies]] | ||
Revision as of 19:50, 27 February 2020
Mechanism of action
Bispecific T-cell engager (BiTE) antibody that engages CD33 and CD3